Lymphatic versus Hematogenous Melanoma Metastases: Support for Biological Heterogeneity without Clear Clinical Application  Gyulnara G. Kasumova, Alex B. Haynes, Genevieve M. Boland  Journal of Investigative Dermatology  Volume 137, Issue 12, Pages 2466-2468 (December 2017) DOI: 10.1016/j.jid.2017.08.029 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Schematic depiction of the populations assessed in MSLT-II, DeCOG-SLT, and Gassenmaier et al. reports. (*Note that in the cohort by Gassenmaier et al. SLNB was only performed starting in 1996.) CLND, completion lymph node dissection; DeCOG-SLT, Dermatologic Cooperative Oncology Group Selective Lymphadenectomy Trial; MLST, Multicenter Selective Lymphadenectomy Trial; SLN, sentinel lymph node; SLNB, sentinel lymph node biopsy; WLE, wide local excision. Journal of Investigative Dermatology 2017 137, 2466-2468DOI: (10.1016/j.jid.2017.08.029) Copyright © 2017 The Authors Terms and Conditions